Alector, Inc.
NASDAQ:ALECBiotechnology
+$0.08 today
- Market cap
- $382.61M
- Beta
- 0.59
- P/E (TTM)
- -1.4
- EPS (TTM)
- -$1.13
Volume 2.13M
Average 0.65M
ALEC Account Payables
Amounts the company owes suppliers for goods and services received.
Alector, Inc.NASDAQ: ALEC
Account Payables · Q1 FY2026 · quarter ended Mar 2026
Account payables falls 38.8% from a year ago
Account payables stood at $1.42M at the end of Q1 FY2026, down 38.8% from a year earlier and down 15.8% from the prior quarter. Over 3 fiscal years it compounded at -26.1% a year.
Context
- Account payables amounted to 0.6% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Account payables increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether account payables keeps falling in the next quarterly balance sheet after a -38.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Account Payables history
USD · from the balance sheet
- Latest · FY2025
- 1.69M USD
- Year-over-year change
- -23.7%
- 4-year CAGR
- -22.8%
| Period | Period end | Account Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.69M | -23.7% |
| FY2024 | 2024-12-31 | 2.22M | -41.3% |
| FY2023 | 2023-12-31 | 3.78M | -9.9% |
| FY2022 | 2022-12-31 | 4.19M | -11.8% |
| FY2021 | 2021-12-31 | 4.75M | — |
Account Payables vs competitors
How ALEC compares with its peers on the latest reported figures
- Peers report in different currencies, so account payables is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -38.8% is the 6th highest of 9, against a peer median of -20.8%.
- Account payables amounts to 0.6% of total assets for ALEC, versus a peer median of 0.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
IRDOpus Genetics, Inc. | Mar 2026 | $4.42M USD | +82.0% | +45.5% | 6.6% |
| Mar 2026 | $3.28M USD | -21.8% | -31.5% | 1.2% | |
| Mar 2026 | CHF 1.92M CHF | -19.9% | -2.0% | 2.2% | |
| Mar 2026 | $1.66M USD | +56.7% | -30.4% | 1.2% | |
| Mar 2026 | $1.59M USD | +6.4% | +5.9% | 0.4% | |
| Mar 2026 | $1.42M USD | -38.8% | -26.1% | 0.6% | |
| Mar 2026 | $1.04M USD | -72.1% | +42.5% | 0.2% | |
| Mar 2026 | $622K USD | -77.0% | -15.5% | 0.4% | |
| Mar 2026 | $435K USD | -89.3% | +0.6% | 0.3% | |
| Peer median (excluding ALEC) | — | -20.8% | -0.7% | 0.8% | |
Competitors are the stored peer set for ALEC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 329.15M | 154.32M | 74.56M | 33.02M | 65.8M |
| Short-term Investments | 406.1M | 558.53M | 474.31M | 380.38M | 190.22M |
| Net Receivables | 7.39M | 2.59M | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 16.95M | 11.42M | 10.43M |
| Total Current Assets | 749.71M | 726.44M | 565.81M | 424.82M | 266.45M |
| Property, Plant & Equipment (Net) | 57.9M | 53.33M | 47.06M | 37.1M | 24.55M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 7.05M | 7.88M | 8.96M | 6.39M | 2.23M |
| Total Non-current Assets | 64.95M | 61.21M | 56.02M | 43.49M | 26.79M |
| Total Assets | 814.66M | 787.65M | 621.83M | 468.3M | 293.24M |
| Account Payables | 4.75M | 4.19M | 3.78M | 2.22M | 1.69M |
| Short-term Debt | 0 | 0 | 0 | 0 | 366K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 90.8M | 48.23M | 82.98M | 23.66M | 6.68M |
| Other Current Liabilities | 11.66M | 12.76M | 54.74M | 54.55M | 24.39M |
| Total Current Liabilities | 139.56M | 93.81M | 177.95M | 125.06M | 69.5M |
| Long-term Debt | 0 | 0 | 0 | 9.39M | 9.32M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 334.42M | 443.37M | 210.85M | 172.17M | 164.54M |
| Other Non-current Liabilities | 158K | 759K | 68.42M | 10.51M | 1.74M |
| Total Non-current Liabilities | 374.38M | 479.4M | 309.72M | 216.44M | 193.09M |
| Total Liabilities | 513.93M | 573.21M | 487.67M | 341.5M | 262.59M |
| Common Stock | 8K | 8K | 8K | 9K | 11K |
| Retained Earnings | (446.38M) | (579.69M) | (710.08M) | (829.13M) | (972.06M) |
| Accumulated OCI | (943K) | (4.58M) | 184K | 261K | 166K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 300.72M | 214.44M | 134.16M | 126.8M | 30.65M |
| Total Debt | 47.6M | 43.33M | 38.92M | 42.52M | 36.23M |
| Net Debt | (281.55M) | (111M) | (35.64M) | 9.5M | (29.57M) |
Alector, Inc.
NASDAQ:ALEC
Intrinsic Alpha fair value
Locked
Current Price
$2.57
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.